Advanced laryngeal cancer: Current best management: "The paradigm is shifting, but not much."

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 10, Issue 2, 2002, Pages 112-117

  Goepfert, Helmuth ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CISPLATIN; FLUOROURACIL; FOLINIC ACID; HYDROXYUREA; PACLITAXEL;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; FUNCTIONAL ASSESSMENT; HUMAN; LARYNX CANCER; LARYNX SURGERY; META ANALYSIS; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; REVIEW; TREATMENT OUTCOME;

EID: 0036208039     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200204000-00009     Document Type: Review

References (35)

1. Validity of the agency for healthcare research and quality clinical practice guidelines: How quickly do guidelines become outdated?
2. Department of Veterans Affairs report
3. The role of partial laryngeal resection in current management of laryngeal cancer: A collective review
4. Surgical approach to organ preservation in the treatment of cancer of the larynx
5. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy
6. The role of irradiation in treatment of cancer of the larynx
7. T3 glottic cancer: Oncologic results and prognostic factors
8. Current role of radiotherapy in the treatment of locally advanced laryngeal carcinomas
9. Assessment of quality of life in patients treated with accelerated radiotherapy for laryngeal and hypopharyngeal carcinomas
10. Glottic cancer in Ontario, Canada and the SEER areas of the United States: Do different management philosophies produce different outcome profiles?
11. Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone. Intergroup trial R91-11
12. Commentary: Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concurrent chemotherapy and radiotherapy versus radiotherapy: Intergroup trial R91-11
13. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data
14. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer
15. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
16. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer
17. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
18. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer
19. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: Toxicities and responses
20. How much does it cost to preserve a larynx? An economic study
21. Current status of voice restoration following total laryngectomy
22. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: Patterns of regional failure
23. The use and misuse of neck dissection for head and neck cancer
24. Complementary and alternative medicine: The role of the cancer center
25. Interactions between academic oncology and alternative/complementary/integrative medicine: Complex but necessary
26. The Edmonton Symptom Assessment System (ESAS)
27. Enhancing doctor-patient communication
28. Quality of life in palliative cancer care: Results from a cluster randomized trial
29. California as a model
30. Behavioral tobacco cessation treatments: Yesterday's news or tomorrow's headlines?
31. Lung cancer chemoprevention: An integrated approach
32. F-18-Fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer